These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 34763595)
1. Enhanced oral bioavailability of koumine by complexation with hydroxypropyl-β-cyclodextrin: preparation, optimization, Hu Q; Fu X; Su Y; Wang Y; Gao S; Wang X; Xu Y; Yu C Drug Deliv; 2021 Dec; 28(1):2415-2426. PubMed ID: 34763595 [TBL] [Abstract][Full Text] [Related]
2. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244 [TBL] [Abstract][Full Text] [Related]
3. Improvement in Solubility-Permeability Interplay of Psoralens from Machado RD; Silva JCG; Silva LAD; Oliveira GAR; Lião LM; Lima EM; de Morais MC; da Conceição EC; Rezende KR Molecules; 2022 Jul; 27(14):. PubMed ID: 35889459 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of the solubility and oral bioavailability of altrenogest through complexation with hydroxypropyl-β-cyclodextrin. Chen W; Zheng X; Lao W; Wang H; Chen S; Liu C; Chen Z; Bai Y; Zhang H; Zhan X; Wang B Eur J Pharm Sci; 2024 Mar; 194():106691. PubMed ID: 38181869 [TBL] [Abstract][Full Text] [Related]
5. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability. Zhang X; Zhang T; Lan Y; Wu B; Shi Z AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778 [TBL] [Abstract][Full Text] [Related]
6. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects. Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterisation of ecdysterone/hydroxypropyl-Β-cyclodextrin inclusion complex with enhanced oral and transdermal bioavailability. Wang L; Li S; Cai H; Liu X; Feng T; Zhao X J Microencapsul; 2022 Mar; 39(2):145-155. PubMed ID: 35311602 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin. Lu Y; Yang L; Zhang W; Xie S; Zhao F; Peng X; Qin Z; Zeng D; Zeng Z Drug Deliv; 2022 Dec; 29(1):2824-2830. PubMed ID: 36062487 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers. Ahmed TA; Bawazir AO; Alharbi WS; Safo MK Int J Nanomedicine; 2020; 15():4001-4020. PubMed ID: 32606661 [TBL] [Abstract][Full Text] [Related]
10. Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes. Zeng F; Wang L; Zhang W; Shi K; Zong L AAPS PharmSciTech; 2013 Jun; 14(2):854-60. PubMed ID: 23649995 [TBL] [Abstract][Full Text] [Related]
11. Liquiritin-Hydroxypropyl-Beta-Cyclodextrin Inclusion Complex: Preparation, Characterization, Bioavailability and Antitumor Activity Evaluation. Wang Q; Zhang K; Weng W; Chen L; Wei C; Bao R; Adu-Frimpong M; Cao X; Yu Q; Shi F; Toreniyazov E; Ji H; Xu X; Yu J J Pharm Sci; 2022 Jul; 111(7):2083-2092. PubMed ID: 35367247 [TBL] [Abstract][Full Text] [Related]
12. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization. Sherje A; Londhe V Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059 [TBL] [Abstract][Full Text] [Related]
13. Complexation of oxethazaine with 2-hydroxypropyl-β-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues. Prado AR; Yokaichiya F; Franco MKKD; Silva CMGD; Oliveira-Nascimento L; Franz-Montan M; Volpato MC; Cabeça LF; de Paula E J Pharm Pharmacol; 2017 Jun; 69(6):652-662. PubMed ID: 28211640 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation. Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807 [TBL] [Abstract][Full Text] [Related]
17. Supersaturated Drug Delivery System of Oxyberberine Based on Cyclodextrin Nanoaggregates: Preparation, Characterization, and in vivo Application. Huang Z; Zhang S; Qin Z; Ai G; Li M; Gong S; Liu Y; Zeng H; Chen J; Su Z; Lai Z Int J Nanomedicine; 2024; 19():5297-5316. PubMed ID: 38859955 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. Patel SG; Rajput SJ AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053 [TBL] [Abstract][Full Text] [Related]
19. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157 [TBL] [Abstract][Full Text] [Related]
20. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics. Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]